NCT02251912View on ClinicalTrials.gov

Oxytocin Treatment of Alcohol Dependence

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Alcohol Dependence
Interventions
DRUG

Intranasal Oxytocin

10 insufflations (40IU of oxytocin total) given 3 initially then 2 times daily for 12 weeks

DRUG

Placebo

10 insufflations (same solution as active treatment minus oxytocin) given 3 initially and then 2 times daily for 12 weeks

Trial Locations (1)

27599

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT02251912 - Oxytocin Treatment of Alcohol Dependence | Biotech Hunter | Biotech Hunter